Merck data and a tumbling stock price cost Armo's investors $320M-plus in Eli Lilly buyout
Usually, being patient in an M&A deal is a big help to the seller. You never take the first offer. You always want more. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
